Trajectories of total depression and depressive symptoms in prostate cancer patients receiving six months of hormone therapy

Christopher F. Sharpley, David R H Christie, Vicki Bitsika, Bradley J. Miller

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)

Abstract

Objective: The aim of this study was to investigate the effects of hormone therapy (HT) on depression and depressive symptoms in prostate cancer patients undergoing 6 months of HT. Methods: One hundred two prostate cancer patients who had been prescribed HT completed the Zung Self-rating Depression Scale (SDS) and two questions about their sexual enjoyment and performance, plus a background questionnaire before HT, after 8 to 10 weeks of HT and again after 16 to 20 weeks of HT. Results: There was a significant increase in SDS scores from before to during HT. High depression score before HT was a significant predictor of later increases in depression during HT. Increases in depressive symptoms were restricted to 8 of the 20 SDS symptoms, the most powerful change being in sexual anhedonia, which was a result of decreased ability to perform during sexual activity. Conclusions: The association between HT and elevated depression is confirmed, but the relative influence of sexual anhedonia over other depressive symptoms expands the understanding of this association. The effects of decreased ability to perform during sex appear to dominate the increase in depression during HT.

Original languageEnglish
Pages (from-to)60-66
Number of pages7
JournalPsycho-Oncology
Volume26
Issue number1
Early online date9 Feb 2016
DOIs
Publication statusPublished - 1 Jan 2017

Fingerprint

Prostatic Neoplasms
Hormones
Depression
Therapeutics
Anhedonia
Aptitude
Sexual Behavior

Cite this

Sharpley, Christopher F. ; Christie, David R H ; Bitsika, Vicki ; Miller, Bradley J. / Trajectories of total depression and depressive symptoms in prostate cancer patients receiving six months of hormone therapy. In: Psycho-Oncology. 2017 ; Vol. 26, No. 1. pp. 60-66.
@article{28e800a8c8ca4484a3bee975aeb0aa35,
title = "Trajectories of total depression and depressive symptoms in prostate cancer patients receiving six months of hormone therapy",
abstract = "Objective: The aim of this study was to investigate the effects of hormone therapy (HT) on depression and depressive symptoms in prostate cancer patients undergoing 6 months of HT. Methods: One hundred two prostate cancer patients who had been prescribed HT completed the Zung Self-rating Depression Scale (SDS) and two questions about their sexual enjoyment and performance, plus a background questionnaire before HT, after 8 to 10 weeks of HT and again after 16 to 20 weeks of HT. Results: There was a significant increase in SDS scores from before to during HT. High depression score before HT was a significant predictor of later increases in depression during HT. Increases in depressive symptoms were restricted to 8 of the 20 SDS symptoms, the most powerful change being in sexual anhedonia, which was a result of decreased ability to perform during sexual activity. Conclusions: The association between HT and elevated depression is confirmed, but the relative influence of sexual anhedonia over other depressive symptoms expands the understanding of this association. The effects of decreased ability to perform during sex appear to dominate the increase in depression during HT.",
author = "Sharpley, {Christopher F.} and Christie, {David R H} and Vicki Bitsika and Miller, {Bradley J.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1002/pon.4100",
language = "English",
volume = "26",
pages = "60--66",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "Wiley Blackwell (American Society Bone & Mineral Research)",
number = "1",

}

Trajectories of total depression and depressive symptoms in prostate cancer patients receiving six months of hormone therapy. / Sharpley, Christopher F.; Christie, David R H; Bitsika, Vicki; Miller, Bradley J.

In: Psycho-Oncology, Vol. 26, No. 1, 01.01.2017, p. 60-66.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Trajectories of total depression and depressive symptoms in prostate cancer patients receiving six months of hormone therapy

AU - Sharpley, Christopher F.

AU - Christie, David R H

AU - Bitsika, Vicki

AU - Miller, Bradley J.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective: The aim of this study was to investigate the effects of hormone therapy (HT) on depression and depressive symptoms in prostate cancer patients undergoing 6 months of HT. Methods: One hundred two prostate cancer patients who had been prescribed HT completed the Zung Self-rating Depression Scale (SDS) and two questions about their sexual enjoyment and performance, plus a background questionnaire before HT, after 8 to 10 weeks of HT and again after 16 to 20 weeks of HT. Results: There was a significant increase in SDS scores from before to during HT. High depression score before HT was a significant predictor of later increases in depression during HT. Increases in depressive symptoms were restricted to 8 of the 20 SDS symptoms, the most powerful change being in sexual anhedonia, which was a result of decreased ability to perform during sexual activity. Conclusions: The association between HT and elevated depression is confirmed, but the relative influence of sexual anhedonia over other depressive symptoms expands the understanding of this association. The effects of decreased ability to perform during sex appear to dominate the increase in depression during HT.

AB - Objective: The aim of this study was to investigate the effects of hormone therapy (HT) on depression and depressive symptoms in prostate cancer patients undergoing 6 months of HT. Methods: One hundred two prostate cancer patients who had been prescribed HT completed the Zung Self-rating Depression Scale (SDS) and two questions about their sexual enjoyment and performance, plus a background questionnaire before HT, after 8 to 10 weeks of HT and again after 16 to 20 weeks of HT. Results: There was a significant increase in SDS scores from before to during HT. High depression score before HT was a significant predictor of later increases in depression during HT. Increases in depressive symptoms were restricted to 8 of the 20 SDS symptoms, the most powerful change being in sexual anhedonia, which was a result of decreased ability to perform during sexual activity. Conclusions: The association between HT and elevated depression is confirmed, but the relative influence of sexual anhedonia over other depressive symptoms expands the understanding of this association. The effects of decreased ability to perform during sex appear to dominate the increase in depression during HT.

UR - http://www.scopus.com/inward/record.url?scp=84975764324&partnerID=8YFLogxK

U2 - 10.1002/pon.4100

DO - 10.1002/pon.4100

M3 - Article

VL - 26

SP - 60

EP - 66

JO - Psycho-Oncology

JF - Psycho-Oncology

SN - 1057-9249

IS - 1

ER -